GLP-1 Drugs Show Promise in Lowering Uterine Fibroid Risk
New research reveals potential protective effects of GLP-1 drugs against uterine fibroids in diabetic women
Study Details:
This study explored the link between GLP-1 receptor agonists—a type of diabetes medication—and the risk of uterine fibroids. Uterine fibroids, common non-cancerous growths in the uterus, are influenced by factors such as insulin resistance, which is often seen in type 2 diabetes. Given the rapid rise in GLP-1 prescriptions, researchers aim…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.